Try our Advanced Search for more refined results
Searching dockets in Heron Therapeutics Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Oral Order ~Util - Set Deadlines
ORAL ORDER: Azurity is directed to provide additional specific information justifying its basis for seeking to maintain the requested portions of the Court's Findings of Fact and Conclusions of Law under seal. The Court notes that the composition of Azurity's NDA product appears to now be a matter of public record by way of its product label and available on the FDA's public website. Azurity is directed to provide a response no later than June 30, 2026. Ordered by Judge William C. Bryson on 06/23/2026. (jfm)
Redacted Document
REDACTED VERSION of 226 Unopposed MOTION to Redact the Court's Findings of Fact and Conclusions of Law (D.I. 221) and the Court's Amended Findings of Fact and Conclusions of Law (D.I. 224) re 224 Findings of Fact & Conclusions of Law, 221 Findings of Fact & by Azurity Pharmaceuticals India LLP, Azurity Pharmaceuticals, Inc., Slayback Pharma LLC. (Hitch, Cortlan)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.